I have to admit that I don't see what Baudax brings to the table for Humanigen, with the possible exception of inking a deal with TeraImmune before we could. But what secrets lie beneath the surface is anyone's guess. Is there something enticing about their neuro-musculature blocking agent, or an untapped use for Anjeso?
There's got to be something, not just worth buying 500K shares of Baudax, but worth buying those shares WHEN we did, which was when we had (or still have) financial constraints.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.